Synthetic organic

InformationDarovasertib (LXS-196) Darovasertib (LXS-196, IDE-196) is a selective inhibitor of protein kinase C (PKC) .TargetsPKC.

InformationDarovasertib (LXS-196) Darovasertib (LXS-196, IDE-196) is a selective inhibitor of protein kinase C (PKC) .TargetsPKC.

InformationDarovasertib (LXS-196) Darovasertib (LXS-196, IDE-196) is a selective inhibitor of protein kinase C (PKC) .TargetsPKC.

InformationDASA-58 DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.TargetsPKM2In vitroDASA-58 inhibits LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes in primary BMDMs, and also

InformationDASA-58 DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.TargetsPKM2In vitroDASA-58 inhibits LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes in primary BMDMs, and also

InformationDASA-58 DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.TargetsPKM2In vitroDASA-58 inhibits LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes in primary BMDMs, and also

InformationDASA-58 DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.TargetsPKM2In vitroDASA-58 inhibits LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes in primary BMDMs, and also

dATPαS.

dATPαS.

DAU 6285.

DAU 6285.

DAV-CRI-14a23e73-1.